Investing.com -- Ipsos shares tumbled more than 4% Friday after the French market research group lowered its 2026 organic growth outlook, even though growth picked up in the third quarter. Ipsos now expects organic growth of 1.2% to 1.5% for the year, down from the previous guidance of about 2%, citing the nine-month performance, its order book and a persistently uncertain macroeconomic and geopolitical backdrop.
Third-quarter revenue was €636.2 million, flat as reported but up 2% organically, compared with 0.8% in the first half. For the first nine months, revenue rose 0.9% to €1.81 billion, with organic growth of 1.2%. The acquisition of The BVA Family added 1.6%, partly offset by the deconsolidation of Russia, and a stronger euro cut 1.9%.
Ipsos said the Middle East, historically a growth region, has been hit by the conflict and declined, which weighed on the outlook. Europe, Central and Eastern Europe, and Africa all grew, and EMEA organic growth was 3.5% in the quarter. Asia-Pacific grew 4.3%, helped by China and India. The Americas fell 1.2%, which Ipsos said remains below its expectations because of delays in executing its Horizons strategic plan in the first half.
By audience, Citizens grew 8.6% and Doctors & Patients grew 5.7%, helped by more U.S. drug approvals. Consumers grew 0.7%, while Clients & Employees fell 2.5%, partly because of a demanding comparison base in advertising campaign measurement. Its Ipsos.Digital platform grew 14%.
Ipsos confirmed it expects an operating margin in line with 2025. Kelly Beaver became chief executive on July 30 and reaffirmed Horizons, with a priority on faster execution.
Original Article
Ipsos shares tumble after lowering full-year growth outlook
Safran drops to five month low as civil aftermarket growth slows in Q3
Hydro shares slump to 13-month low as Q3 earnings miss forecasts
